Obesity Drug Turns Arena Into Biggest Loser

September 18, 2010   |   September 2010 Bond Updates
Shares plummet after FDA advisory committee votes against approval of lorcaserin weight loss drug.

View more at: http://www.forbes.com/2010/09/17/todays-big-losers-arna-orex-mee-marketnewsvideo.html?feed=rss_markets
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/